Christian Kurt Hirt, M.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dioxygenases | 1 | 2023 | 316 | 0.790 |
Why?
|
| Organoids | 2 | 2022 | 701 | 0.670 |
Why?
|
| Bioreactors | 2 | 2019 | 236 | 0.630 |
Why?
|
| Myeloproliferative Disorders | 1 | 2023 | 606 | 0.590 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 3523 | 0.380 |
Why?
|
| Fluorouracil | 1 | 2015 | 1619 | 0.370 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1276 | 0.350 |
Why?
|
| Neoplasms | 4 | 2023 | 21683 | 0.320 |
Why?
|
| Cell Culture Techniques | 3 | 2022 | 1678 | 0.290 |
Why?
|
| Tissue Engineering | 1 | 2015 | 1880 | 0.250 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 5 | 2018 | 1038 | 0.230 |
Why?
|
| Sarcoma, Myeloid | 1 | 2023 | 59 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 345 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2015 | 5172 | 0.190 |
Why?
|
| Interleukin-17 | 2 | 2015 | 899 | 0.160 |
Why?
|
| HT29 Cells | 2 | 2015 | 200 | 0.160 |
Why?
|
| Models, Biological | 1 | 2014 | 9583 | 0.150 |
Why?
|
| Pancreas | 2 | 2021 | 1686 | 0.150 |
Why?
|
| Laminin | 1 | 2018 | 419 | 0.140 |
Why?
|
| Fibrin | 1 | 2018 | 506 | 0.140 |
Why?
|
| Colorectal Neoplasms | 4 | 2019 | 6773 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2021 | 1117 | 0.130 |
Why?
|
| Tissue Scaffolds | 2 | 2019 | 956 | 0.130 |
Why?
|
| Rectal Neoplasms | 2 | 2014 | 1206 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2021 | 1092 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 5256 | 0.120 |
Why?
|
| Biomimetics | 1 | 2015 | 172 | 0.120 |
Why?
|
| Peroxidase | 2 | 2015 | 611 | 0.120 |
Why?
|
| Epithelium | 1 | 2018 | 1679 | 0.120 |
Why?
|
| Hydrogels | 1 | 2018 | 724 | 0.110 |
Why?
|
| Fucosyltransferases | 1 | 2013 | 119 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 990 | 0.110 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 868 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 2541 | 0.100 |
Why?
|
| Prognosis | 7 | 2023 | 29063 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 675 | 0.100 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 640 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 2942 | 0.100 |
Why?
|
| Equipment Design | 2 | 2019 | 3582 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2022 | 198 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 903 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1634 | 0.090 |
Why?
|
| DNA Mismatch Repair | 1 | 2013 | 426 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2018 | 4479 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 2540 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2015 | 766 | 0.090 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2013 | 450 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2014 | 1133 | 0.080 |
Why?
|
| Tissue Array Analysis | 3 | 2014 | 553 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3586 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2023 | 7880 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10481 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 9648 | 0.070 |
Why?
|
| Phenotype | 4 | 2018 | 16365 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2021 | 3752 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1988 | 0.060 |
Why?
|
| Monocytes | 1 | 2014 | 2596 | 0.060 |
Why?
|
| Neutrophils | 2 | 2015 | 3719 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2007 | 437 | 0.060 |
Why?
|
| Mutation | 3 | 2023 | 29786 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8428 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1526 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3703 | 0.050 |
Why?
|
| Humans | 17 | 2023 | 744343 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 7322 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2022 | 23403 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9438 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2022 | 209 | 0.050 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2021 | 38 | 0.050 |
Why?
|
| Receptors, IgG | 2 | 2015 | 582 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 146 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 16689 | 0.050 |
Why?
|
| Macrophages | 1 | 2014 | 5655 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 627 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2007 | 1177 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9734 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13284 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 290 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 743 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 351 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11483 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 3616 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4838 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2015 | 64 | 0.030 |
Why?
|
| Chemokine CXCL9 | 1 | 2015 | 132 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 209 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2015 | 304 | 0.030 |
Why?
|
| Perfusion | 1 | 2019 | 1360 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1692 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2014 | 137 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 193 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2022 | 2440 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 168757 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 690 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2023 | 2948 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 57776 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6538 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 1241 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 434 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 294 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 3144 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12788 | 0.020 |
Why?
|
| Collagen | 1 | 2019 | 2689 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 713 | 0.020 |
Why?
|
| Chemokines | 1 | 2014 | 970 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11366 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 11031 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1821 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5853 | 0.020 |
Why?
|
| Aged | 6 | 2015 | 163280 | 0.020 |
Why?
|
| Switzerland | 1 | 2007 | 255 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 2924 | 0.020 |
Why?
|
| Female | 8 | 2021 | 380194 | 0.020 |
Why?
|
| Middle Aged | 6 | 2015 | 213383 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.020 |
Why?
|
| Adult | 6 | 2015 | 214055 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 3567 | 0.020 |
Why?
|
| Male | 7 | 2021 | 350118 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3479 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 15997 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2014 | 21746 | 0.010 |
Why?
|
| Liver | 1 | 2018 | 7474 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2013 | 4026 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5974 | 0.010 |
Why?
|
| Point Mutation | 1 | 2007 | 1623 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3588 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10252 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12245 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6933 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12797 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81183 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 3444 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12951 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39050 | 0.010 |
Why?
|